1.
A comparative study to evaluate salivary biomarker interleukin-6 in oral squamous cell carcinoma and oral potentially malignant disorders. CDF. 2025;54(2):864-868. Accessed January 30, 2026. https://cuestionesdefisioterapia.com/index.php/es/article/view/804